We are pleased to share the latest update on a significant breakthrough in diabetes treatment from our team at Biotts.… Read More »MEDIA: Biotts’ Insulin Patch – A Game-Changer for Diabetes Patients

We are pleased to share the latest in-vivo results from our ongoing research together with Bioton into our innovative transdermal… Read More »MTC-I Transdermal Insulin: New In-Vivo Results

Biotts, in collaboration with Bioton S.A., has achieved a historic milestone by successfully delivering insulin through a transdermal patch, eliminating… Read More »Media: Biotts Becomes First Company to Successfully Deliver Insulin Through Skin

At Biotts, our partnership with Bioton has been on an exciting journey towards revolutionizing transdermal insulin delivery. We are proud… Read More »Transdermal Insulin Delivery: Progress from the Biotts-Bioton Partnership

The LSX World Congress has come to an end, and what an incredible event it was! We had numerous insightful… Read More »biotts recap from lsx world congress 2024

We are thrilled to continue our mission of educating the world about the groundbreaking potential of transdermal drug delivery and… Read More »Join Biotts at SusHi Tech Tokyo 2024!

At Biotts, we’re committed to pioneering advancements in biotechnology that revolutionize healthcare. Our innovative solutions have garnered attention in the… Read More »Biotts in media

We’re thrilled to announce that at the end of April (29-30.04), we’ll be heading to London for the 10th LSX… Read More »Join Us at LSX in london- meet with our ceo

Managing diabetes effectively often involves regular insulin administration, which can be challenging for patients due to the need for frequent… Read More »FIRST EVER NONINVASIVE insulin – preclinical results